AU
ERAS icon

AlphaGrep UK’s Erasca ERAS Stock Holding History

AlphaGrep UK’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
+20,340
New +$291K 0.11% 356

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

AlphaGrep UK's ERAS Position: Q2 2026 in Review

AlphaGrep UK opened a new position in Erasca (ERAS) in Q2 2026: 20,340 shares worth $373K. The stake represents 0.11% of the portfolio and ranks #356 among its holdings.

239 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • AlphaGrep UK held 20,340 shares of Erasca worth $373K as of Q2 2026.
  • Erasca was a new AlphaGrep UK position in Q2 2026.
  • Erasca made up 0.11% of AlphaGrep UK's portfolio in Q2 2026, its #356 holding.
  • 239 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.